BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Galapagos NV 

Industriepark Mechelen Noord I, Zone L
Generaal De Wittelaan 11 A
Mechelen    B-2800  Belgium
Phone: 32-15-34-29-00 Fax: 32-15-34-29-01


SEARCH JOBS




Industry
Biotechnology






 Company News
Galapagos NV (GLPG.BR) Creates New Warrant Plan 7/25/2014 2:51:50 PM
MorphoSys AG And Galapagos NV (GLPG.BR) Advance Joint Antibody Program In Inflammatory Diseases Into Preclinical Development 7/23/2014 8:21:22 AM
Galapagos NV (GLPG.BR) Raises €1.9 Million Through Warrant Exercises 7/7/2014 7:54:12 AM
Galapagos NV (GLPG.BR) Initiates Phase 1 Study With GLPG1690, Triggering €6.6 M Milestone In The Alliance With Janssen Pharmaceutica N.V. 7/1/2014 9:13:37 AM
Galapagos NV (GLPG.BR) Cystic Fibrosis Program Progresses Towards Therapy For Largest Patient Group 6/17/2014 8:46:04 AM
Galapagos NV (GLPG.BR) To Hold Annual R&D Update On 17 June 2014 In New York 5/12/2014 11:54:15 AM
Galapagos NV (GLPG.BR) Release: Invitation To The Extraordinary General Shareholders' Meeting To Be Held On 19 May 2014 4/30/2014 4:05:22 PM
Galapagos NV (GLPG.BR) Announces Management Change 4/28/2014 8:55:00 AM
Galapagos NV (GLPG.BR) Release: GSK2586184 Met Primary Endpoint In Phase 2a Psoriasis Study 4/17/2014 9:36:13 AM
Galapagos NV (GLPG.BR) Raises €2.4 Million Through Warrant Exercises 4/10/2014 3:01:54 PM
12345678910...